Finance
Results: 12493-12504 of 49311

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

REVEAL GENOMICS Aligns Founder Leadership With Priorities to Support Long-term Growth, Scientific Excellence, and Global Partnerships

ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership








